Patent waivers alone may not lead to quick vaccine access, say experts
The waiving off of patents alone is unlikely to help improve vaccine availability anytime soon, scientists, legal experts and pharma industry executives said, pointing to the complicated technical know-how, raw materials and infrastructure required to make vaccines while ensuring they are as safe and effective as the original developer intended it to be. Several countries, … Patent waivers alone may not lead to quick vaccine access, say experts






















